Navigation Links
Morning Sickness Drug Gets Green Light in Study

Israeli researchers find short-term use during pregnancy should be safe,,,,

WEDNESDAY, June 10 (HealthDay News) -- A new study suggests that women who experience morning sickness early in pregnancy can safely take the medication metoclopramide to relieve their symptoms.

The study, which included nearly 3,500 pregnant women who took metoclopramide (Reglan), a drug developed to treat gastrointestinal (GI) problems, found no significant increases in the risk of birth defects, premature delivery, low birth weight or fetal death.

"It appears that metoclopramide is safe for short-term use to control GI problems in pregnant women when used as prescribed," said the study's senior author, Amalia Levy, a senior lecturer in epidemiology at Ben-Gurion University of the Negev in Israel. "Physicians are reassured about the safety of metoclopramide use in pregnancy in recommended doses."

Results of the study appear in the June 11 issue of the New England Journal of Medicine.

In Europe and in Israel, metoclopramide is often prescribed early in pregnancy to help quell that queasy feeling so common in the first trimester, according to the study's authors. Yet, like many drugs used in pregnancy, the effects of the drug on the growing fetus have not been well-studied. In the United States, the medication is usually reserved for women with severe morning sickness because it has not been approved by the Food and Drug Administration for use in pregnancy, the authors report.

And despite the study's findings, the use of metoclopramide is not without controversy. In February, the FDA added what's known as a "black box" warning to metoclopramide to alert people that long-term use of the medication (more than 12 weeks) or its use at high dosages has been associated with serious side effects. After long-term use, some people develop uncontrollable movements of the limb, face and tongue that don't go away even after they stop taking the drug.

But, the current study focused only on short-term use during pregnancy, and Levy said that use of metoclopramide in pregnancy is "usually for short terms and as needed."

For the study, the researchers reviewed 81,703 births between 1998 and 2007, all to mothers registered with a particular Israeli health system that has a computerized database of medical information. From that group, 3,458 women -- 4.2 percent -- were given metoclopramide during the first trimester of their pregnancies.

The study found no significantly increased health risks for babies of women exposed to the drug compared with the offspring of women who hadn't taken it. The risk of birth defects, for instance, was 5.3 percent in the metoclopramide group and 4.9 percent in the group not exposed to the drug. The researchers also found no significantly increased risk of low birth weight, premature delivery or fetal death.

"We worry about women with extensive nausea and vomiting during pregnancy," said Dr. Eva Pressman, director of maternal fetal medicine at the University of Rochester Medical Center in New York. "There's concern about dehydration and losing weight. The largeness of this study is clearly better than anything we've had to date on the safety of metoclopramide, and it shows that there are safe medications that you can use in pregnancy."

Pregnant women who are having morning sickness shouldn't just suffer through it, Pressman said. Instead, she said, talk to a doctor about ways to lessen the stomach upset.

More information

The March of Dimes has more on coping with nausea during pregnancy.

SOURCES: Amalia Levy, Ph.D., senior lecturer, Department of Epidemiology and Health Service Evaluation, Ben-Gurion University of the Negev, Israel; Eva Pressman, M.D., director, maternal fetal medicine, University of Rochester Medical Center, Rochester, N.Y.; June 11, 2009, New England Journal of Medicine

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
2. Pro-Life Spokeswoman Objects to FDA Approval of Morning-After Pill for Minors Without Prescription
3. The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More than $800,000 in National Radiothon Benefiting St. Jude
4. Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue
5. AUDIO from Medialink and Kellogg: The Morning Blues Just Got Better
6. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
7. US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
8. Browning/Duke LLC and Medco Donate Land in Anson to Morning Dove
9. Corner stores capture kids on morning commute
10. Morningness a predictor of better grades in college
11. Morning Sickness Magic(TM) - An Effective Natural Approach to Morning Sickness
Post Your Comments:
Related Image:
Morning Sickness Drug Gets  Green Light in Study
(Date:11/30/2015)... ... , ... The Foundation for Breast and Prostate Health (FBPH)—a ... with the award-winning creator and writer of Downton Abbey Julian Fellowes to host ... Union League of Philadelphia. , The benefit, titled “An Evening with Julian ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties products ... markets in the US, effective immediately. , “We are pleased to announce ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i Systems, a ... today that Michigan-based Family Health Center (FHC) has selected i2iTracks as their population ... was awarded the largest Affordable Care Act grant for Federally Qualified Health Centers ...
(Date:11/30/2015)... PITTSBURGH, PA (PRWEB) , ... November 30, 2015 , ... ... quality of life in the womb. "My last baby had high blood pressure due ... way for mothers to protect their babies from noise pollution as well as radio ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an interview with Andy ... a top ophthalmologist on Long Island’s east end. During the broadcast, entitled “Eyes: the ... and treatment of glaucoma and cataracts, and how a visit with his grandmother to ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... KIRKLAND, Wash. , Nov. 30, 2015 /PRNewswire/ ... of Post-Processing services, is pleased to announce a ... of medical imaging services. Building on its ISO-9001:2008 ... adopted and implemented comprehensive Core Lab protocols and ... wide variety of research activities.  Their Core Lab ...
(Date:11/30/2015)... 30, 2015 Mexico Healthcare and Life Sciences ... Report 2015 . --> Pharmaboardroom releases its new 98-page ... Latin America , a country of over 122 million ... of over 122 million people. --> It offers companies, ... life sciences insights into the second largest pharma and healthcare market ...
(Date:11/30/2015)... , November 30, 2015 Elbit ... the "Company") announced today that it was informed by InSightec ... Drug Safety (MFDS) has approved its Exablate Neuro system ... --> --> Insightec,s Exablate Neuro ... alternative that combines two technologies: Focused Ultrasound, which is ...
Breaking Medicine Technology: